The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1979, 123: 2447-2450.
Copyright © 1979 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jandinski, J. J.
Right arrow Articles by Scott, D. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jandinski, J. J.
Right arrow Articles by Scott, D. W.

Role of Self Carriers in the Immune Response and Tolerance

IV. Active T Cell Suppression in the Maintenance of B Cell Tolerance to a "T-Independent" Antigen1

John J. Jandinski2 and David W. Scott3

From the Division of Immunology, Department of Microbiology and Immunology, Duke University Medical Center Durham, North Carolina 27710

Abstract

Previous studies indicated that T cells are required for tolerance induction by hapten-modified syngeneic spleen cells (TNP-SC) in vivo. The role of T cells in the maintenance of this unresponsive state has been examined herein. By three criteria—limiting dilution precursor analysis, removal of T cells by anti-Thy-1 + C, and direct mixing experiments—we show that T cells are required for the continued suppression of the B cell response to the T-independent antigen, TNP-POL. Suppressor cells can also be induced by TNP-teratoma cells, which lack detectable H-2 antigens. Both anti-Ly-1 + C and anti-Ly-2 + C treatment reversed suppression induced by TNP-SC. These results demonstrate that normal B cell reactivity is present in the spleens of mice rendered tolerant by haptenated self, but that Ly-1,2,3 or Ly-1 + Ly-2,3 suppressor T cells prevent their responsiveness.

Footnotes

1 This work was supported by United States Public Health Service Grant CA-22845 from the National Cancer Institute.

2 Supported by United States Public Health Service Training Grant T32 GM-07003, and Grant CA-22845 from the National Cancer Institute. Present address: Merck, Sharpe & Dohme, Co., Division of Immunology, P.O. Box 2000, Rahway, New Jersey.

3 Research Career Development Awardee AI-00093.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.